
Third Rock Ventures takes aggressive approach to biotech
Third Rock Ventures is taking an aggressive approach to biotech start-ups, investing $1.3 billion in 32 companies since 2006. Read the article from MedCity News here.
Third Rock Ventures is taking an aggressive approach to biotech start-ups, investing $1.3 billion in 32 companies since 2006. Read the article from MedCity News here.